ZEVRA THERAPEUTICS, INC. Quarterly Return On Equity in % from Q3 2015 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Zevra Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from Q3 2015 to Q3 2024.
  • Zevra Therapeutics, Inc. Return On Equity for the quarter ending September 30, 2024 was -168 %, a 426% decline year-over-year.
  • Zevra Therapeutics, Inc. annual Return On Equity for 2023 was -76.3 %, a 177% decline from 2022.
  • Zevra Therapeutics, Inc. annual Return On Equity for 2022 was -27.5 %, a 260% decline from 2021.
  • Zevra Therapeutics, Inc. annual Return On Equity for 2021 was -7.63 %, a 139% decline from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -168 -136 -426% Jul 1, 2024 Sep 30, 2024
Q2 2024 -131 -107 -463% Apr 1, 2024 Jun 30, 2024
Q1 2024 -85.6 -39 -83.8% Jan 1, 2024 Mar 31, 2024
Q4 2023 -76.3 -48.8 -177% Oct 1, 2023 Dec 31, 2023
Q3 2023 -32 +1.82 +5.38% Jul 1, 2023 Sep 30, 2023
Q2 2023 -23.2 +3.54 +13.2% Apr 1, 2023 Jun 30, 2023
Q1 2023 -46.6 -46.5 -45872% Jan 1, 2023 Mar 31, 2023
Q4 2022 -27.5 -19.9 -260% Oct 1, 2022 Dec 31, 2022
Q3 2022 -33.9 -18.6 -121% Jul 1, 2022 Sep 30, 2022
Q2 2022 -26.8 +28.8 +51.8% Apr 1, 2022 Jun 30, 2022
Q1 2022 -0.1 -64.6 -100% Jan 1, 2022 Mar 31, 2022
Q4 2021 -7.63 -27.2 -139% Oct 1, 2021 Dec 31, 2021
Q3 2021 -15.3 -36.1 -174% Jul 1, 2021 Sep 30, 2021
Q2 2021 -55.5 -66.9 -588% Apr 1, 2021 Jun 30, 2021
Q1 2021 64.5 +40.1 +165% Jan 1, 2021 Mar 31, 2021
Q4 2020 19.6 -12.9 -39.7% Oct 1, 2020 Dec 31, 2020
Q3 2020 20.8 -11.5 -35.6% Jul 1, 2020 Sep 30, 2020
Q2 2020 11.4 -41.2 -78.3% Apr 1, 2020 Jun 30, 2020
Q1 2020 24.4 -28.8 -54.1% Jan 1, 2020 Mar 31, 2020
Q4 2019 32.5 -36.9 -53.2% Oct 1, 2019 Dec 31, 2019
Q3 2019 32.3 -46 -58.8% Jul 1, 2019 Sep 30, 2019
Q2 2019 52.5 -31.9 -37.8% Apr 1, 2019 Jun 30, 2019
Q1 2019 53.1 -41.8 -44% Jan 1, 2019 Mar 31, 2019
Q4 2018 69.5 -27.6 -28.4% Oct 1, 2018 Dec 31, 2018
Q3 2018 78.3 -43.9 -35.9% Jul 1, 2018 Sep 30, 2018
Q2 2018 84.5 -97.2 -53.5% Apr 1, 2018 Jun 30, 2018
Q1 2018 94.9 -97.7 -50.7% Jan 1, 2018 Mar 31, 2018
Q4 2017 97.1 -69.6 -41.8% Oct 1, 2017 Dec 31, 2017
Q3 2017 122 -81 -39.9% Jul 1, 2017 Sep 30, 2017
Q2 2017 182 +2.31 +1.29% Apr 1, 2017 Jun 30, 2017
Q1 2017 193 -672 -77.7% Jan 1, 2017 Mar 31, 2017
Q4 2016 167 -161 -49.1% Oct 1, 2016 Dec 31, 2016
Q3 2016 203 -14.8 -6.8% Jul 1, 2016 Sep 30, 2016
Q2 2016 179 Apr 1, 2016 Jun 30, 2016
Q1 2016 865 Jan 1, 2016 Mar 31, 2016
Q4 2015 328 Oct 1, 2015 Dec 31, 2015
Q3 2015 218 Jul 1, 2015 Sep 30, 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.